ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Psittacosis

Psittacosis
Literature review current through: Jan 2024.
This topic last updated: Aug 23, 2022.

INTRODUCTION — Psittacosis, also known as ornithosis, is usually a disease with prominent systemic manifestations and some respiratory symptoms. This infection, caused by Chlamydia psittaci, is transmitted to humans predominantly from birds.

The epidemiology, clinical features, diagnosis, and treatment of psittacosis will be discussed here. Pneumonia caused by Chlamydia spp is discussed separately. (See "Pneumonia caused by Chlamydia pneumoniae in adults" and "Pneumonia caused by Chlamydia pneumoniae in children".)

MICROBIOLOGY — C. psittaci is an obligate intracellular bacterium. There are 10 known genotypes based on sequencing of the major outer protein gene, ompA [1]. Each genotype has host preferences and virulence characteristics, although these overlap. Knowledge of the pathogenesis at a cellular and molecular level is growing [2].

EPIDEMIOLOGY — Psittacosis has been recognized throughout the world, including the United States, the United Kingdom, Europe, the Middle East, and Australia. In a meta-analysis of observational studies, C. psittaci, the causative agent of psittacosis, was estimated to cause approximately 1 percent of cases of community-acquired pneumonia [3]. However, the precise incidence and prevalence of psittacosis is difficult to establish, likely due to lack of routine testing [4] and varying sensitivity and specificity of commonly used diagnostic tests. As the use of molecular diagnostic assays increases, knowledge of the epidemiology of psittacosis is expected to grow [5-7]. Certain genotypes may predominate in specific regions [8].

Birds are the primary reservoir, but transmission from other animals has also been reported. The disease usually occurs sporadically, but outbreaks caused by contact with an infected bird are not uncommon [9]. As an example, in 2018, an outbreak of 82 cases occurred in two poultry slaughter plants in the United States [10]. Outbreaks related to pet shops, aviaries, veterinary facilities, poultry flocks, and turkey and duck processing have also been described [11-16].

Birds — Most patients with psittacosis have a history of contact with birds. C. psittaci has been documented in at least 460 species from 30 bird orders, including turkeys, pheasants, chickens [17], and even ostriches and penguins [18]. Migratory birds, including geese, may carry this pathogen [19]. Most humans are infected from birds of the order Psittaciformes, which includes parakeets (budgerigars), cockatiels, cockatoos, and parrots. In France, mule ducks are associated with human disease through heavy shedding, although the ducks are asymptomatic [20]. Each bird order tends to be infected by a predominant genotype of C. psittaci.

Of 1136 patients reported to the United States Centers for Disease Control and Prevention (CDC) between 1975 and 1984, 72 percent had a history of contact with birds as pets or in a domestic setting, 6 percent had contact with wild birds, 12 percent were poultry workers, and only 10 percent had no recognized avian contact [9]. Pigeons may be an especially significant source in springtime [21]. In a Chinese study, 65 percent of patients had exposure to poultry or parrots [22]. In one Australian study, infection was much more prevalent in captive birds (8 percent) than wild birds (0.7 percent) [23]. Veterinarians, veterinary technicians, zoo workers, pet shop owners [24], duck farmers, poultry workers [25-27], custom officers [28], and farmers can be infected. Fatalities have occurred in occupationally exposed workers [29]. In China, 12 percent of adult pet birds were seropositive in a 2014 survey [30]. Investigation of an outbreak in Sydney, Australia, revealed that, in some regions, psittacosis was endemic through bird exposure [31].

The incubation period in birds is extremely variable, from three days for acute disease to years for reactivation of latent infection, often at a time of stress. Infection in birds is usually asymptomatic or may cause lethargy, anorexia, ruffled feathers, ocular or nasal discharge, or diarrhea. Some birds die rapidly; others become wasted or dehydrated. The organism is shed in feces, urine, and respiratory secretions. Once feces dry, the organism may become airborne as droplet nuclei. Dried organisms remain viable for months at room temperature.

Transmission from infected birds may not always require direct contact. In an investigation of 16 infected patients during an outbreak in a rural Australian town, cases spent more time gardening and were more likely to have mowed the lawn in the three weeks preceding illness than controls, but the feeding and keeping of domestic or wild birds was not associated with infection [32].

Other species — Transmission of infection from other animals to humans is rare. Certain strains of C. psittaci may infect sheep, goats, cats, dogs, dairy cattle, and horses, causing placental insufficiency, abortion, and a chronic respiratory infection. Exposures to the birth fluids and placentas of infected animals can lead to infection in humans. For example, an Australian outbreak affecting five staff in a veterinary school was traced to horse exposure through equine fetal membranes [33]. Equine psittacosis should be considered in the diagnosis of equine pregnancy losses and neonatal foals, with veterinary exposure risk at these events [34]. Severe human disease in pregnancy contracted from lambing sheep is also well recognized [35]. To avoid this risk, pregnant women should avoid contact with birthing sheep, goats, and other farm animals and their gestational products. Feline keratoconjunctivitis agent (a strain of C. psittaci), which produces rhinitis and conjunctivitis in cats, is rarely transmitted to humans [36]. Children have acquired psittacosis from infected dogs; clinical manifestations in dogs include recurrent conjunctivitis, small litter size, and respiratory distress [37].

Human disease — Humans are usually infected by inhalation of organisms in dried feces when caged birds exercise their wings or in bird feather dust. Cage cleaning may pose an infection risk [15]. Bird bites, mouth-to-beak contact, and even transient exposure, such as visiting a bird park, have also been implicated in the transmission of this infection. Virtually all pet birds can carry C. psittaci, but psittacine birds are the most likely to be infected. Less frequently, pigeons, doves, and mynahs carry infection. In an Italian series of 76 cases, most human infections were contracted from poultry [38]. Outbreaks associated with chicken slaughter plants have occurred, with those working with eviscerating birds most at risk. Some workers experienced severe illness requiring intensive care unit admission [23].

Human-to-human transmission may occur, but has been considered rare, with limited reports in the past. In Sweden, one severely ill patient with psittacosis transmitted infection to 10 others, including a hospital roommate and 7 hospital staff [39,40]. In an outbreak in a duck meat processing plant in China, transmission initially occurred from avian to human; later secondary and tertiary human-to-human transmission occurred. This included several transmissions from asymptomatic carriers, and transmission by health care workers. With metagenomic diagnosis revealing new understandings of the epidemiology of this infection, C. psittaci should be considered a biosecurity risk [41].

Psittacosis is most common in young and middle-aged adults, although it has been described in all age groups. In several series, but not all, a marked predilection for males is noted, presumably related to increased potential for exposure [42,43].

Infection is not always associated with a major illness. When avian chlamydiosis was detected in a large shipment of pet birds, households exposed were investigated. Eleven percent of exposed persons developed an acute respiratory illness. Clinical or serological evidence of infection was found in 30 percent of households. In many, infection led to mild illness or was asymptomatic [44]. However, deaths are occasionally reported [45].

In 2014, a total of 8 psittacosis cases were reported in the United States [46], compared with an average of 10 cases (range 2 to 21) reported annually during the period 2005 to 2011 [47].

CLINICAL FEATURES — C. psittaci infection of humans most commonly presents in young or middle-aged adults as fever of abrupt onset, pronounced headache, and dry cough. Infection can also be asymptomatic. Patients usually have a recent history of bird exposure. The incubation period is usually between 5 and 14 days but can be as long as 39 days [48]. In one study of 135 patients, systemic manifestations were prominent with fever in all patients, rigors occurring in 61 percent, and sweats and myalgias in most patients [42]. Though cough was present in 82 percent of patients, it frequently developed late. Other respiratory symptoms, including dyspnea, chest pain, and hemoptysis, were present in 24 percent of patients. Eighteen percent of patients had no respiratory symptoms.

The clinical presentation may mimic coronavirus disease 2019 (COVID-19). In a case series reported in China, the white cell count, neutrophil count, and calcium were more likely to be decreased in patients with COVID-19. The lung lesions in patients with psittacosis were more likely to be unilateral, involve fewer lobes, and have pleural effusions (although these are not common) [49].

Headache is common, usually severe, and may be accompanied by photophobia. One-third of the 135 patients in the above series underwent lumbar puncture for possible meningitis [42].

Other less common but important symptoms include pharyngitis, diarrhea, and altered mental status. Diarrhea may be seen in up to 25 percent of patients and is typically mild. It can be quite severe, however, and even be the most prominent symptom in some patients [42]. Twelve percent of patients present with altered mental status, which can range from mild confusion to, rarely, overt encephalitis [50].

Physical examination — Most patients have some abnormalities on chest examination (usually rales), occasionally have evidence of consolidation, and uncommonly have a pleural rub. Relative bradycardia with pneumonia is said to be suggestive [51]. Pleural effusions occur infrequently and are rare enough to prompt reconsideration of the diagnosis. Splenomegaly and hepatomegaly occur in approximately 10 percent of patients [42].

Organ system complications — Complications in a number of organ systems may arise in patients with psittacosis. These are uncommon manifestations of the illness, but some can be severe.

Pulmonary — Occasionally, respiratory failure occurs requiring ventilatory support and can be fatal. In a report from the Netherlands, 8 of 12 patients with severe respiratory failure died [52]. Patients with fulminant pneumonia often also manifest neurologic, renal, and gastrointestinal complications [52-54]. Severe pneumonia was associated with higher levels of procalcitonin, urea nitrogen, lactate dehydrogenase, creatinine kinase, myoglobin, interleukin 6, and lower lymphocyte and CD8-positive T cell counts [55]. Progression less acutely to a life threatening, probable organizing pneumonia has also been described, when there may be a role for corticosteroid therapy [56].

Hematologic complications in fulminant disease include disseminated intravascular coagulation [57,58] and hemophagocytic syndrome [59,60].

Renal disease — Mild renal involvement with proteinuria and occasional oliguria is well recognized [61]. Rarely, acute tubular necrosis may occur in fulminant psittacosis with respiratory failure. Acute tubulointerstitial nephritis and acute proliferative glomerulonephritis have also been reported [62].

Hematologic complications — Cold agglutinins are sometimes noted in psittacosis, but hemolytic anemia with jaundice is rare [63]. Acute thrombocytopenic purpura, severe pancytopenia secondary to hemophagocytic syndrome, and thrombotic thrombocytopenic purpura in a patient with respiratory failure have also been described.

Liver disease — Icteric hepatitis occurs uncommonly [64]. One patient with multiple nodules in the liver and spleen who had a pericardial rub but no evidence of pulmonary disease was found to have hepatic granulomas and serological evidence of psittacosis [65].

Neurologic disease — A wide range of neurologic syndromes are infrequently seen, although abnormal neurologic findings are less common than with mycoplasma infection. Encephalitis was seen in 2 of 156 patients in a series from the United Kingdom [66]. Cerebellar disturbance may be prominent. Psychiatric symptoms and intracranial hypertension have been described [9]. True meningitis with a cerebrospinal fluid pleocytosis may occur rarely. Positive metagenomics sequencing of the cerebrospinal fluid has been reported [67,68]. One patient presenting with status epilepticus suffered a protracted and severe neurologic illness. Direct invasion of the central nervous system was demonstrated by Chlamydia deoxyribonucleic acid (DNA) in cerebrospinal fluid [69].

Uveitis has been seen in association with meningitis. Palsies of the 4th, 6th, 7th, and 12th cranial nerve have been described, often accompanying overt encephalitis [70]. Diplopia may persist for months. Transient sensorineural deafness associated with pneumonia has been reported [71]. Transverse myelitis with fever can also be the clinical presentation of psittacosis [72]. The neurologic deficit may or may not resolve. In addition, Guillain-Barré syndrome can follow acute infection [50].

Musculoskeletal — Reactive arthritis, though rare, has been reported. The onset may be a week or more after the first symptoms of psittacosis [73]. Migratory small and large joint arthritis, symmetrical polyarthritis, and reactive arthritis (formerly Reiter syndrome) have been described [74,75]. Human leukocyte antigen-type associations have been noted [76]. Rhabdomyolysis has also occurred with severe pneumonia [42,77,78].

Skin manifestations — Dermatologic manifestations are infrequent. Erythema nodosum is the most frequent, but erythema multiforme, erythema marginatum, "Horder spots," and panniculitis also have been reported [79].

Chronic follicular conjunctivitis — Conjunctivitis with enlarged preauricular nodes and punctuate epithelioid keratitis, without any associated systemic symptoms, has been reported in bird fanciers and laboratory workers [80,81]. This may be unilateral, and diagnosis made on polymerase chain reaction testing rather than serology [82].

Endocarditis, myocarditis, and pericarditis — Endocarditis caused by C. psittaci is rare [83]. It should be considered in the differential diagnosis of culture-negative endocarditis usually lasting weeks or months, especially if there is a history of bird exposure. Serologic evidence of infection should then be sought. Surgery is often required, and a mortality of 50 percent has been reported [84,85]. If the patient comes to surgery, electron microscopy and immunofluorescent staining of valvular tissue is suggested. Although there is anecdotal evidence to suggest tetracycline treatment without surgery may at times be adequate, the optimal duration of treatment is unknown [86]. Myocarditis and pericarditis are also rare. Myocarditis may lead to left ventricular dilatation, but limited reports suggest resolution of myocardial damage with therapy [87,88].

Infection in pregnancy — Infection in pregnancy may be life-threatening, particularly in the late second or third trimester [89]. Respiratory failure, liver dysfunction, and disseminated intravascular coagulation may threaten the life of the mother. Eleven of 14 pregnant women died in a psittacosis outbreak in 1938. Fetal outcome is poor, with fetal death in 11 of 14 reported cases [90].

The infection may cross the placenta and cause intrauterine fetal compromise. The organism has a predilection for the placenta. Placental histopathologic findings consist of an intense acute intervillositis, perivillous fibrin deposition with villous necrosis, and large irregular basophilic intracytoplasmic inclusions within the syncytiotrophoblast [91]. These changes can impair fetoplacental blood flow and increase the risk of bacterial embolization to the fetus [89]. Although rare, infections with ovine C. psittaci are a particular hazard for pregnant women, in whom there is severe placentitis and frequently fetal loss. Such infections are mainly associated with contact with lambing sheep [90,91].

Association with ocular adnexal lymphoma — There are conflicting reports regarding a possible causal association between psittacosis and ocular adnexal lymphoma (OAL) as well as the response of OAL to treatment with antibiotics. Reports suggest a response rate of this indolent lymphoma to antibiotic therapy for C. psittaci of 33 to 65 percent [92]. (See "Clinical manifestations, pathologic features, and diagnosis of extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT)", section on 'Chlamydia psittaci'.)

Laboratory studies — The white cell count is usually normal, but the differential may show toxic granulation or a "left shift." Occasionally, there is a marked leukocytosis. The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and procalcitonin are very often elevated. In an Australian series, the mean peak ESR was 50 mm/hour, and CRP was 129 mg/L [42]. The liver enzymes are abnormal in approximately half of hospitalized patients, usually with mild elevation of the aspartate transaminase and low serum albumin levels. Hyponatremia is quite common, as is mild elevation of serum creatinine and blood urea nitrogen. Serum creatinine kinase levels are infrequently elevated [93].

Chest radiology — The chest radiograph is abnormal in approximately 80 percent of cases, most often with lobar changes; such changes were observed more frequently in the lower lobes in some series [94]. Approximately one-quarter of patients have multilobar changes, and slightly fewer have a normal chest radiograph [43]. Air space consolidation or ground-glass opacities have also been reported. Pleural effusions are rare but can occur. Migratory infiltrates have also been described [95]. On high-resolution computed tomography, the pulmonary infiltrates may be nodular surrounded by ground-glass opacities [96].

Cerebrospinal fluid — In patients undergoing lumbar puncture, elevation of cerebrospinal fluid protein levels is frequently observed. Elevated cerebrospinal fluid white blood cell counts occur rarely.

PATHOLOGY — There is limited knowledge of the pathology of psittacosis, since lung biopsies are rarely performed in this setting.

Infectious elementary bodies enter respiratory epithelial cells and convert to replicating reticulate bodies, which are metabolically active structures that are 10 to 100 times larger than elementary bodies [97,98]. These subsequently change back to elementary bodies that are released to infect other cells in the same individual or to infect others.

At the macroscopic level, the lungs have patchy consolidation that may be lobar or lobular. The consolidated area is usually hemorrhagic. Adjacent pleura may show fibrinous pleurisy, but effusions are uncommon.

Microscopically, as with other causes of bacterial pneumonia, exudation is more marked than interstitial changes. The exudate consists of fibrin, neutrophils, and hemorrhage. There is a mixed lymphocytic and neutrophilic infiltrate in the interstitium. The changes are concentrated in terminal bronchioles spreading to adjacent alveoli and then the whole lobule. Necrosis of bronchiolar and bronchus epithelium may occur, as may capillary thrombosis leading to alveolar necrosis. Later, the alveoli develop a lining of swollen epithelial cells. Healing through repair may lead to an organizing pneumonia.

The Chlamydia are just visible with the light microscope as cytoplasmic inclusion bodies 0.25 to 0.5 mm diameter. These are basophilic and best seen with Giemsa stain.

DIAGNOSIS — The typical clinical features (fever, headache, myalgias, dry cough) in a patient with a history of bird contact should suggest the diagnosis and should prompt the initiation of appropriate treatment. In a patient presenting with pneumonia, severe headache, splenomegaly, and failure to respond to beta-lactam antibiotics may be other clues to the diagnosis.

Differential diagnosis — The differential diagnosis of psittacosis is broad but can be narrowed based on the particular clinical presentation of the patient.

For a patient with atypical pneumonia, the other etiologies to consider include Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella infection. (See "Pneumonia caused by Chlamydia pneumoniae in adults" and "Pneumonia caused by Chlamydia pneumoniae in children" and "Mycoplasma pneumoniae infection in adults" and "Clinical manifestations and diagnosis of Legionella infection" and "Mycoplasma pneumoniae infection in children", section on 'Clinical manifestations'.)

If the patient primarily has a febrile illness without localizing signs, influenza, endocarditis, septicemia, vasculitis, Coxiella burnetii infection, leptospirosis, and brucellosis should also be considered. (See "Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis" and "Brucellosis: Epidemiology, microbiology, clinical manifestations, and diagnosis".)

When extrapulmonary manifestations predominate, the patient should be evaluated for the causes of the most prominent manifestation such as gastroenteritis, hepatitis, meningitis, or encephalitis.

Specific diagnostic tests — The diagnosis of psittacosis is typically established by serologic testing. Culture is discouraged since C. psittaci is highly infectious when cultured and is only performed in specialized laboratories. All of the available diagnostic tests have major limitations, as discussed below.

Serology — Since culture is both difficult and dangerous, serology is the principal method of confirming the diagnosis. There are two types of serologic tests available: complement fixation (CF) and microimmunofluorescent (MIF) antibody test. When available, we favor MIF testing, but CF testing may be used as an alternative.

MIF test – The MIF test is the most sensitive and specific serologic test for C. psittaci but is only available in specialty laboratories [99]. The antigen used is Chlamydia species-specific surface antigen. An MIF test showing a fourfold rise in antibodies or an immunoglobulin (Ig)M antibody titer ≥16 is interpreted as diagnostic. As the serologic response seen in both CF and MIF is often unimpressive, a single antibody titer of ≥32 in either test combined with a typical history is sufficient for a diagnosis of "probable psittacosis."

A number of studies reevaluated by MIF cases that were diagnosed as psittacosis based upon clinical history and a positive CF test. C. psittaci was confirmed in 32 to 77 percent of patients [99-101]. A history of bird contact increased the probability of the diagnosis of C. psittaci, and clustering of cases in a family increased the probability of C. pneumoniae.

CF test – The CF test is the test that has been used traditionally to make the diagnosis. It is the most widely available test but unfortunately cannot differentiate among the chlamydial species. The antigen used is a lipopolysaccharide present in the outer membrane of all Chlamydia spp. Paired acute and convalescent sera should be obtained at least two weeks apart, and a fourfold rise in antibody levels is significant. If there are clinical grounds for suspecting psittacosis and no antibody response is detected, the CF test should be repeated in another two weeks. Treatment with tetracycline may delay or diminish the antibody response.

Monoclonal antibody techniques — Monoclonal antibody techniques, which use antibodies directed against the chlamydial antigens (genus-specific lipopolysaccharides), show promise. Direct immunofluorescent antibody staining of respiratory secretions (sputum, pharyngeal swabs) has been used for rapid diagnosis [102]. Studies that demonstrate the sensitivity and specificity of these techniques are needed.

DNA-based assays — Polymerase chain reaction (PCR) methods for the detection of C. psittaci have been developed [103,104]. They have been used in outbreak investigations and give a rapid and specific diagnosis [10,105,106]. Initial results from nested PCR for C. psittaci suggest good specificity but less sensitivity than for C. pneumoniae [105]. Touchdown enzyme time-release PCR assays have been used to amplify different DNA sequences in the variable regions of the 16S and 16S-23S spacer ribosomal ribonucleic acid (rRNA) genes specific for Chlamydia trachomatis, C. pneumoniae, and C. psittaci and have potential as improved tests for sensitive diagnosis and rapid species differentiation in chlamydial infections [106,107]. A real-time PCR assay to detect DNA in human clinical samples targeting ompA genes also offers potential as a sensitive, specific, and rapid method of diagnosis from respiratory samples [108]. DNA may be detected in whole blood, throat specimens, urine [109], and feces [10]. In a United States outbreak, C. psittaci was detected by real-time PCR in only 7 percent of upper respiratory specimens, but more frequently in lower respiratory tract specimens (59 percent) and feces (four of five patients). PCR testing of sputum, when available, in all community-acquired pneumonia patients in a Dutch study led to an increased recognition of psittacosis as a pathogen compared with previous studies of pneumonia in that setting (4.8 versus 0 to 2.1 percent) [110]. A subsequent study that used multiplex PCR assays to evaluate patients with lower respiratory tract infections also found that the prevalence of psittacosis was higher than previously estimated [6]. Diagnosis through next-generation metagenomic sequencing has been described and will likely allow rapid diagnosis and increase recognition of this disease in the future [45,111-114]. Some platforms also include information regarding antibiotic susceptibility [115]. Bronchoalveolar lavage specimens may give the optimal diagnostic yield, over sputum and blood. A Chinese report suggests superior sensitivity over real-time PCR [116].

Commercial multiplex PCR assays do not test for C. psittaci [117,118].

Culture — Culture is discouraged, except in specialized laboratories. C. psittaci can be isolated from sputum, pleural fluid, and autopsy specimens of lungs, liver, and spleen [48]. However, it is highly infectious when cultured, and the danger of aerosol transmission to laboratory personnel is significant.

C. pneumoniae, a frequent consideration in the differential diagnosis, is particularly difficult to culture. (See "Pneumonia caused by Chlamydia pneumoniae in adults", section on 'Diagnosis'.)

TREATMENT — The tetracyclines are preferred for the treatment of psittacosis, but other agents have been proposed as alternatives. Macrolides are frequently used in the treatment of community-acquired pneumonia in the absence of a microbiologic diagnosis and are highly likely to be effective for psittacosis.

Tetracyclines — Tetracyclines are the drugs of choice. Doxycycline (100 mg orally twice daily) usually produces a rapid clinical response in patients with mild to moderate disease. Doxycycline can be given intravenously in critically ill patients. In one series, 92 percent of patients defervesced within 48 hours of commencing treatment with one of these agents [42]. However, occasional treatment failures and relapses are recognized. Minocycline has also been used with success. Although the optimal duration of therapy for psittacosis has not been determined, we generally treat for 7 to 10 days when using a tetracycline.

Macrolides — A macrolide, such as erythromycin or azithromycin, is usually recommended as the second-line therapy when the tetracyclines are contraindicated. In one study of five patients treated with erythromycin, the response appeared equivalent to tetracyclines [119]. If azithromycin is used, treatment duration may be shortened to five days if there is a prompt clinical response. (See "Pneumonia caused by Chlamydia pneumoniae in adults".)

Macrolides remain the agents of choice in children with mild to moderate infection. Treatment in pregnancy is controversial and is influenced by anecdotal reports. Two women with gestational psittacosis failed to respond to erythromycin but improved with doxycycline and delivery [89,120]. Some authors have therefore suggested that doxycycline should be the agent of choice in pregnancy. Azithromycin shows good activity in vitro and in animal models, but adequate clinical data are lacking. We believe that azithromycin is a reasonable choice in pregnant women and children <8 years of age, in whom doxycycline is typically avoided. We favor azithromycin over erythromycin since azithromycin is better tolerated.

Other drugs — Chloramphenicol and rifampin have been used successfully, but relapses have occurred with both agents. Ofloxacin proved effective in the treatment of 13 patients [121], but the role of quinolones in this infection requires further evaluation.

PREVENTION

Vaccine — Early work identifying vaccine candidate antigens in mice has been undertaken, but no vaccine has been developed to date [122,123].

PUBLIC HEALTH ISSUES — Many health authorities require clinicians to report patients with psittacosis [9]. Reporting facilitates the recognition of outbreaks and the evaluation and treatment of the birds that are the source. If the source bird has the diagnosis of psittacosis confirmed and has been purchased from a shop or breeder in the preceding two months, an epidemiologic investigation should be undertaken. Others in contact with infected birds should be warned of the possibility of disease. Infected birds should be isolated and treated.

Patients recovering from psittacosis will often ask if they should destroy their pet bird if they developed psittacosis following exposure to the bird, but this is not usually necessary. Psittacosis of the bird can usually be cured or suppressed with antibiotic treatment alone. If the bird is kept in poor or crowded conditions, stress may be contributing to the shedding of organisms and should be corrected.

Aviaries with infected birds should be cleaned according to published guidelines [124]. Techniques to prevent aerosolization of infected particles during this procedure are necessary. In some poultry plants, where ducks and other poultry living in an aqueous habitat are slaughtered and processed, there may be a high risk of C. psittaci infection and ornithosis morbidity [125]. Preventive measures (eg, gloves, masks, information, and medical examinations of the workers) should be implemented in such plants when C. psittaci is common [126]. In a community outbreak situation, gardening practices may need to be examined and modified [32].

The Swedish outbreak with in-hospital transmission described above [39] raises concerns that stricter hospital infection control measures than those currently used may be indicated. (See 'Human disease' above.)

C. psittaci is a "category B" bioterrorism agent. Disease could be spread by aerosol [127]. (See "Identifying and managing casualties of biological terrorism", section on 'Organisms of concern'.)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Community-acquired pneumonia in adults".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topic (see "Patient education: Psittacosis (The Basics)")

SUMMARY AND RECOMMENDATIONS

Avian borne respiratory illness − Psittacosis is a disease with prominent systemic manifestations and some respiratory symptoms. This infection, caused by Chlamydia psittaci, is transmitted to humans predominantly from birds. (See 'Introduction' above.)

Worldwide geographic distribution − Psittacosis has been recognized throughout the world, including the United States, the United Kingdom, Europe, the Middle East, and Australia. Birds are the primary reservoir, but transmission from other animals has also been reported. The disease usually occurs sporadically, but outbreaks caused by contact with an infected bird are not uncommon. (See 'Epidemiology' above.)

Bird exposure and incubation period − Humans are usually infected by inhalation of organisms in dried feces when caged birds exercise their wings or in bird feather dust. Cage cleaning may pose an infection risk. Bird bites, mouth-to-beak contact, and even transient exposure, such as visiting a bird park, have also been implicated in the transmission of this infection. The incubation period is usually 5 to 14 days. (See 'Human disease' above.)

Clinical manifestationsC. psittaci infection of humans most commonly presents in young or middle-aged adults as fever of abrupt onset, pronounced headache, and dry cough. Patients usually have a recent history of bird exposure. Most patients have some abnormalities on chest examination (usually rales), may have evidence of consolidation, and uncommonly have a pleural rub. (See 'Clinical features' above and 'Physical examination' above.)

Complications − Complications in a number of organ systems may arise in patients with psittacosis. These are uncommon manifestations of the illness, but some can be severe. Examples include respiratory failure, hepatitis, endocarditis, and encephalitis. Infection in pregnancy may be life-threatening. (See 'Organ system complications' above.)

Chest imaging − The chest radiograph is usually abnormal, most often with lobar changes. Approximately one-quarter of patients have multilobar changes, and slightly fewer have a normal chest radiograph. On high-resolution computed tomography, the pulmonary infiltrates may be nodular surrounded by ground-glass opacities. (See 'Chest radiology' above.)

When to suspect psittacosis − The typical clinical features (fever, headache, myalgias, dry cough) in a patient with a history of bird contact should suggest the diagnosis and should prompt the initiation of appropriate treatment. In a patient presenting with pneumonia, severe headache, splenomegaly, and failure to respond to beta-lactam antibiotics may be other clues to the diagnosis. (See 'Diagnosis' above.)

Confirming the diagnosis − The diagnosis of psittacosis is typically established by serologic testing. When available, we favor microimmunofluorescent antibody testing, but the complement fixation assay may be used as an alternative. Culture is discouraged since C. psittaci is highly infectious when cultured and is only performed in specialized laboratories. (See 'Specific diagnostic tests' above.)

Preferred antibiotic treatment − We recommend the tetracyclines as first-line therapy for psittacosis. Doxycycline (100 mg orally twice daily) usually produces a rapid clinical response in patients with mild to moderate disease. Tetracycline hydrochloride or doxycycline (4.4 mg/kg per day divided into two daily doses) is given intravenously in critically ill patients. We generally treat for 7 to 10 days. (See 'Tetracyclines' above.)

Alternative treatment − A macrolide such as erythromycin or azithromycin is usually recommended as second-line therapy when the tetracyclines are contraindicated. (See 'Macrolides' above.)

ACKNOWLEDGMENT — UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.

  1. Wolff BJ, Morrison SS, Pesti D, et al. Chlamydia psittaci comparative genomics reveals intraspecies variations in the putative outer membrane and type III secretion system genes. Microbiology 2015; 161:1378.
  2. Knittler MR, Sachse K. Chlamydia psittaci: update on an underestimated zoonotic agent. Pathog Dis 2015; 73:1.
  3. Hogerwerf L, DE Gier B, Baan B, VAN DER Hoek W. Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis. Epidemiol Infect 2017; 145:3096.
  4. Rybarczyk J, Versteele C, Lernout T, Vanrompay D. Human psittacosis: a review with emphasis on surveillance in Belgium. Acta Clin Belg 2020; 75:42.
  5. Cadario ME, Frutos MC, Arias MB, et al. Epidemiological and molecular characteristics of Chlamydia psittaci from 8 human cases of psittacosis and 4 related birds in Argentina. Rev Argent Microbiol 2017; 49:323.
  6. Rane V, Khailin K, Williams J, et al. Underdiagnosis of Chlamydia trachomatis and Chlamydia psittaci revealed by introduction of respiratory multiplex PCR assay with Chlamydiaceae family primers. Diagn Microbiol Infect Dis 2018; 90:163.
  7. Marking U, Hammas B, Grabbe M, Giske C. [Psittacosis - a forgotten diagnosis in Sweden?]. Lakartidningen 2018; 115.
  8. Wang C, Li L, Xie Y, et al. Isolation and Characterization of Avian Chlamydia psittaci from Symptomatic Pet Birds in Southern Hunan, China. Avian Dis 2019; 63:31.
  9. Saeki S, Hirata I, Fukusako T, et al. [A case of psittacosis with psychiatric symptoms, abnormal EEG, and abnormal SPECT]. No To Shinkei 1996; 48:1141.
  10. McGovern OL, Kobayashi M, Shaw KA, et al. Use of Real-Time PCR for Chlamydia psittaci Detection in Human Specimens During an Outbreak of Psittacosis - Georgia and Virginia, 2018. MMWR Morb Mortal Wkly Rep 2021; 70:505.
  11. Gaede W, Reckling KF, Dresenkamp B, et al. Chlamydophila psittaci infections in humans during an outbreak of psittacosis from poultry in Germany. Zoonoses Public Health 2008; 55:184.
  12. Mohan R. Epidemiologic and laboratory observations of Chlamydia psittaci infection in pet birds. J Am Vet Med Assoc 1984; 184:1372.
  13. Schlossberg D, Delgado J, Moore MM, et al. An epidemic of avian and human psittacosis. Arch Intern Med 1993; 153:2594.
  14. Hedberg K, White KE, Forfang JC, et al. An outbreak of psittacosis in Minnesota turkey industry workers: implications for modes of transmission and control. Am J Epidemiol 1989; 130:569.
  15. Hinton DG, Shipley A, Galvin JW, et al. Chlamydiosis in workers at a duck farm and processing plant. Aust Vet J 1993; 70:174.
  16. Heddema ER, van Hannen EJ, Duim B, et al. An outbreak of psittacosis due to Chlamydophila psittaci genotype A in a veterinary teaching hospital. J Med Microbiol 2006; 55:1571.
  17. Čechová L, Halánová M, Babinská I, et al. Chlamydiosis in farmed chickens in Slovakia and zoonotic risk for humans. Ann Agric Environ Med 2018; 25:320.
  18. Kaleta EF, Taday EM. Avian host range of Chlamydophila spp. based on isolation, antigen detection and serology. Avian Pathol 2003; 32:435.
  19. Dickx V, Kalmar ID, Tavernier P, Vanrompay D. Prevalence and genotype distribution of Chlamydia psittaci in feral Canada geese (Branta canadensis) in Belgium. Vector Borne Zoonotic Dis 2013; 13:382.
  20. Vorimore F, Thébault A, Poisson S, et al. Chlamydia psittaci in ducks: a hidden health risk for poultry workers. Pathog Dis 2015; 73:1.
  21. Trávnicek M, Cisláková L, Deptuła W, et al. Wild pigeons and pheasants--a source of Chlamydophila psittaci for humans and animals. Ann Agric Environ Med 2002; 9:253.
  22. Li X, Xiao T, Hu P, et al. Clinical, radiological and pathological characteristics of moderate to fulminant psittacosis pneumonia. PLoS One 2022; 17:e0270896.
  23. Shaw KA, Szablewski CM, Kellner S, et al. Psittacosis Outbreak among Workers at Chicken Slaughter Plants, Virginia and Georgia, USA, 2018. Emerg Infect Dis 2019; 25:2143.
  24. Halsby KD, Walsh AL, Campbell C, et al. Healthy animals, healthy people: zoonosis risk from animal contact in pet shops, a systematic review of the literature. PLoS One 2014; 9:e89309.
  25. Laroucau K, de Barbeyrac B, Vorimore F, et al. Chlamydial infections in duck farms associated with human cases of psittacosis in France. Vet Microbiol 2009; 135:82.
  26. Dickx V, Geens T, Deschuyffeleer T, et al. Chlamydophila psittaci zoonotic risk assessment in a chicken and turkey slaughterhouse. J Clin Microbiol 2010; 48:3244.
  27. Amery-Gale J, Legione AR, Marenda MS, et al. SURVEILLANCE FOR CHLAMYDIA SPP. WITH MULTILOCUS SEQUENCE TYPING ANALYSIS IN WILD AND CAPTIVE BIRDS IN VICTORIA, AUSTRALIA. J Wildl Dis 2020; 56:16.
  28. Mamma M, Spandidos DA. Customs officers in relation to viral infections, tuberculosis, psittacosis and environmental health risk. Exp Ther Med 2019; 17:1149.
  29. Petrovay F, Balla E. Two fatal cases of psittacosis caused by Chlamydophila psittaci. J Med Microbiol 2008; 57:1296.
  30. Cong W, Huang SY, Zhang XX, et al. Chlamydia psittaci exposure in pet birds. J Med Microbiol 2014; 63:578.
  31. Branley JM, Weston KM, England J, et al. Clinical features of endemic community-acquired psittacosis. New Microbes New Infect 2014; 2:7.
  32. Williams J, Tallis G, Dalton C, et al. Community outbreak of psittacosis in a rural Australian town. Lancet 1998; 351:1697.
  33. Chan J, Doyle B, Branley J, et al. An outbreak of psittacosis at a veterinary school demonstrating a novel source of infection. One Health 2017; 3:29.
  34. Jelocnik M. Chlamydiae from Down Under: The Curious Cases of Chlamydial Infections in Australia. Microorganisms 2019; 7.
  35. Kampinga GA, Schröder FP, Visser IJ, et al. [Lambing ewes as a source of severe psittacosis in a pregnant woman]. Ned Tijdschr Geneeskd 2000; 144:2500.
  36. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 1998. Center for Disease Control and Prevention. MMWR Recomm Rep 1998; 47:1.
  37. Sprague LD, Schubert E, Hotzel H, et al. The detection of Chlamydophila psittaci genotype C infection in dogs. Vet J 2009; 181:274.
  38. Maffei C, Marracino A, Di Stanislao F, et al. Psittacosis in a highly endemic area in Italy. Epidemiol Infect 1987; 99:413.
  39. Wallensten A, Fredlund H, Runehagen A. Multiple human-to-human transmission from a severe case of psittacosis, Sweden, January-February 2013. Euro Surveill 2014; 19.
  40. Hughes C, Maharg P, Rosario P, et al. Possible nosocomial transmission of psittacosis. Infect Control Hosp Epidemiol 1997; 18:165.
  41. Zhang Z, Zhou H, Cao H, et al. Human-to-human transmission of Chlamydia psittaci in China, 2020: an epidemiological and aetiological investigation. Lancet Microbe 2022; 3:e512.
  42. Yung AP, Grayson ML. Psittacosis--a review of 135 cases. Med J Aust 1988; 148:228.
  43. Sahn SA. Pleural effusions in the atypical pneumonias. Semin Respir Infect 1988; 3:322.
  44. Moroney JF, Guevara R, Iverson C, et al. Detection of chlamydiosis in a shipment of pet birds, leading to recognition of an outbreak of clinically mild psittacosis in humans. Clin Infect Dis 1998; 26:1425.
  45. Chen X, Cao K, Wei Y, et al. Metagenomic next-generation sequencing in the diagnosis of severe pneumonias caused by Chlamydia psittaci. Infection 2020; 48:535.
  46. Adams DA, Thomas KR, Jajosky RA, et al. Summary of Notifiable Infectious Diseases and Conditions - United States, 2014. MMWR Morb Mortal Wkly Rep 2016; 63:1.
  47. Adams DA, Jajosky RA, Ajani U, et al. Summary of notifiable diseases--United States, 2012. MMWR Morb Mortal Wkly Rep 2014; 61:1.
  48. Grayston JT, Thom DH. The chlamydial pneumonias. Curr Clin Top Infect Dis 1991; 11:1.
  49. Zhao W, He L, Xie XZ, et al. Clustering cases of Chlamydia psittaci pneumonia mimicking COVID-19 pneumonia. World J Clin Cases 2021; 9:11237.
  50. Hughes P, Chidley K, Cowie J. Neurological complications in psittacosis: a case report and literature review. Respir Med 1995; 89:637.
  51. Fukui S, Kawamura W, Uehara Y, Naito T. A patient with psittacosis from a pigeon: A reminder of the importance of detailed interviews and relative bradycardia. IDCases 2021; 25:e01164.
  52. Verweij PE, Meis JF, Eijk R, et al. Severe human psittacosis requiring artificial ventilation: case report and review. Clin Infect Dis 1995; 20:440.
  53. Taniguchi H, Mukae H, Ihiboshi H, et al. [A case of fulminant psittacosis necessitating mechanical ventilation diagnosed by chlamydial isolation form BALF]. Kansenshogaku Zasshi 1995; 69:1396.
  54. Garo B, Garre M, Boles JM, et al. [Severe pneumopathy and acute renal insufficiency disclosing Chlamydia psittaci infection: resistance to the treatment with erythromycin]. Ann Med Interne (Paris) 1987; 138:296.
  55. Su S, Su X, Zhou L, et al. Severe Chlamydia psittaci pneumonia: clinical characteristics and risk factors. Ann Palliat Med 2021; 10:8051.
  56. Zuzek R, Green M, May S. Severe psittacosis progressing to suspected organizing pneumonia and the role of corticosteroids. Respir Med Case Rep 2021; 34:101486.
  57. Hamilton DV. Psittacosis and disseminated intravascular coagulation. Br Med J 1975; 2:370.
  58. Laidlaw E, Mulligan RA. Letter: Psittacosis and disseminated intravascular coagulation. Br Med J 1975; 2:688.
  59. Sun L, Li P, Pang B, et al. Gestational Psittacosis With Secondary Hemophagocytic Syndrome: A Case Report and Literature Review. Front Med (Lausanne) 2021; 8:755669.
  60. Wong KF, Chan JK, Chan CH, Lim WW. Psittacosis-associated hemophagocytic syndrome. Am J Med 1991; 91:204.
  61. Mason AB, Jenkins P. Acute renal failure in fulminant psittacosis. Respir Med 1994; 88:239.
  62. Jeffrey RF, More IA, Carrington D, et al. Acute glomerulonephritis following infection with Chlamydia psittaci. Am J Kidney Dis 1992; 20:94.
  63. Timmerman R, Bieger R. Haemolytic anaemia due to cold agglutinins caused by psittacosis. Neth J Med 1989; 34:306.
  64. Samra Z, Pik A, Guidetti-Sharon A, et al. Hepatitis in a family infected by Chlamydia psittaci. J R Soc Med 1991; 84:347.
  65. Carella G, Marra L, Vallot T. [Hepatic psittacosis: a case of liver abnormality diagnosed by ultrasonography]. Presse Med 1996; 25:197.
  66. Anonymous. More psittacosis. BMJ 1973; 3:704.
  67. Adachi K, Hosokawa T, Watanabe Y, et al. [A case of psittacosis meningitis complicated with uveitis]. Rinsho Shinkeigaku 1989; 29:122.
  68. Shi Y, Chen J, Shi X, et al. A case of chlamydia psittaci caused severe pneumonia and meningitis diagnosed by metagenome next-generation sequencing and clinical analysis: a case report and literature review. BMC Infect Dis 2021; 21:621.
  69. Walder G, Schönherr H, Hotzel H, et al. Presence of Chlamydophila psittaci DNA in the central nervous system of a patient with status epilepticus. Scand J Infect Dis 2003; 35:71.
  70. Newton P, Lalvani A, Conlon CP. Psittacosis associated with bilateral 4th cranial nerve palsies. J Infect 1996; 32:63.
  71. Brewis C, McFerran DJ. 'Farmer's ear': sudden sensorineural hearing loss due to Chlamydia psittaci infection. J Laryngol Otol 1997; 111:855.
  72. Crook T, Bannister B. Acute transverse myelitis associated with Chlamydia psittaci infection. J Infect 1996; 32:151.
  73. Lanham JG, Doyle DV. Reactive arthritis following psittacosis. Br J Rheumatol 1984; 23:225.
  74. Tsapas G, Klonizakis I, Casakos K, Koncouris L. Psittacosis and arthritis. Chemotherapy 1991; 37:143.
  75. Bhopal RS, Thomas GO. Psittacosis presenting with Reiter's syndrome. Br Med J (Clin Res Ed) 1982; 284:1606.
  76. Davison S. Reactive arthritis and psittacosis. Am J Med 1987; 82:385.
  77. Kawamura S, Ikematsu H, Ogimoto H. [Two cases of psittacosis accompanied with rhabdomyolysis]. Kansenshogaku Zasshi 1990; 64:1239.
  78. Zhang A, Xia X, Yuan X, et al. Severe Chlamydia psittaci Pneumonia Complicated by Rhabdomyolysis: A Case Series. Infect Drug Resist 2022; 15:873.
  79. Macheta MP, Ackrill P, August PJ. Psittacosis, panniculitis and clofazimine. J Infect 1994; 28:69.
  80. Lietman T, Brooks D, Moncada J, et al. Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae. Clin Infect Dis 1998; 26:1335.
  81. Dean D, Shama A, Schachter J, Dawson CR. Molecular identification of an avian strain of Chlamydia psittaci causing severe keratoconjunctivitis in a bird fancier. Clin Infect Dis 1995; 20:1179.
  82. Vandendriessche S, Rybarczyk J, Schauwvlieghe PP, et al. A Bird's-Eye View of Chronic Unilateral Conjunctivitis: Remember about Chlamydia psittaci. Microorganisms 2019; 7.
  83. Fernández-Guerrero ML. Zoonotic endocarditis. Infect Dis Clin North Am 1993; 7:135.
  84. Levison DA, Guthrie W, Ward C, et al. Infective endocarditis as part of psittacosis. Lancet 1971; 2:844.
  85. Lamáury I, Sotto A, Le Quellec A, et al. Chlamydia psittaci as a cause of lethal bacterial endocarditis. Clin Infect Dis 1993; 17:821.
  86. Walker LJ, Adgey AA. Successful treatment by doxycycline of endocarditis caused by ornithosis. Br Heart J 1987; 57:58.
  87. Schinkel AF, Bax JJ, van der Wall EE, Jonkers GJ. Echocardiographic follow-up of Chlamydia psittaci myocarditis. Chest 2000; 117:1203.
  88. Falces Salvador C, Moleiro Oliva A, Barcons Vergés M, et al. [Acute pericarditis with effusion as a form of presentation of psittacosis]. Rev Esp Cardiol 1999; 52:727.
  89. Gherman RB, Leventis LL, Miller RC. Chlamydial psittacosis during pregnancy: a case report. Obstet Gynecol 1995; 86:648.
  90. Jorgensen DM. Gestational psittacosis in a Montana sheep rancher. Emerg Infect Dis 1997; 3:191.
  91. Hyde SR, Benirschke K. Gestational psittacosis: case report and literature review. Mod Pathol 1997; 10:602.
  92. Raderer M, Kiesewetter B, Ferreri AJ. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin 2016; 66:153.
  93. Crosse BA. Psittacosis: a clinical review. J Infect 1990; 21:251.
  94. Kuwabara M, Tanemori N, Kawaguti Y, et al. [Clinical features of 36 cases of psittacosis]. Kansenshogaku Zasshi 1990; 64:498.
  95. Yamato H, Segawa K, Tsuda T, et al. [A case of psittacosis with migratory infiltrates]. Nihon Kyobu Shikkan Gakkai Zasshi 1992; 30:100.
  96. Hochhegger B, Marchiori E, Irion KL, et al. Psittacosis presenting as a halo sign on high-resolution computed tomography. J Thorac Imaging 2009; 24:136.
  97. Corrin B, Nicholson AG. Pathology of the Lungs, 2nd Ed, Churchill Livingstone, New York, New York 2005. p.185.
  98. Procop GW, Tazelaar HD. Bacterial infections of the lungs and upper airways. In: Thurlbeck's Pathology of the Lung, 3rd Ed, Churg AM, Myers JL, Tozelaar HD, Wright JC (Eds), Thieme, New York, New York 2005. p.204.
  99. Wreghitt T. Chlamydial infection of the respiratory tract. Commun Dis Rep CDR Rev 1993; 3:R119.
  100. Persson K, Treharne J. Diagnosis of infection caused by Chlamydia pneumoniae (strain TWAR) in patients with "ornithosis" in southern Sweden 1981-1987. Scand J Infect Dis 1989; 21:675.
  101. Bruu AL, Haukenes G, Aasen S, et al. Chlamydia pneumoniae infections in Norway 1981-87 earlier diagnosed as ornithosis. Scand J Infect Dis 1991; 23:299.
  102. Oldach DW, Gaydos CA, Mundy LM, Quinn TC. Rapid diagnosis of Chlamydia psittaci pneumonia. Clin Infect Dis 1993; 17:338.
  103. Wolff BJ, Morrison SS, Winchell JM. Development of a multiplex TaqMan real-time PCR assay for the detection of Chlamydia psittaci and Chlamydia pneumoniae in human clinical specimens. Diagn Microbiol Infect Dis 2018; 90:167.
  104. Nieuwenhuizen AA, Dijkstra F, Notermans DW, van der Hoek W. Laboratory methods for case finding in human psittacosis outbreaks: a systematic review. BMC Infect Dis 2018; 18:442.
  105. Messmer TO, Skelton SK, Moroney JF, et al. Application of a nested, multiplex PCR to psittacosis outbreaks. J Clin Microbiol 1997; 35:2043.
  106. Madico G, Quinn TC, Boman J, Gaydos CA. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol 2000; 38:1085.
  107. Toyokawa M, Kishimoto T, Cai Y, et al. Severe Chlamydophila psittaci pneumonia rapidly diagnosed by detection of antigen in sputum with an immunochromatography assay. J Infect Chemother 2004; 10:245.
  108. Heddema ER, Beld MG, de Wever B, et al. Development of an internally controlled real-time PCR assay for detection of Chlamydophila psittaci in the LightCycler 2.0 system. Clin Microbiol Infect 2006; 12:571.
  109. Branley JM, Roy B, Dwyer DE, Sorrell TC. Real-time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster. Eur J Clin Microbiol Infect Dis 2008; 27:269.
  110. Spoorenberg SM, Bos WJ, van Hannen EJ, et al. Chlamydia psittaci: a relevant cause of community-acquired pneumonia in two Dutch hospitals. Neth J Med 2016; 74:75.
  111. Gu L, Liu W, Ru M, et al. The application of metagenomic next-generation sequencing in diagnosing Chlamydia psittaci pneumonia: a report of five cases. BMC Pulm Med 2020; 20:65.
  112. Li N, Li S, Tan W, et al. Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19. Emerg Microbes Infect 2021; 10:1418.
  113. Davar K, Wilson MR, Miller S, et al. A Rare Bird: Diagnosis of Psittacosis Meningitis by Clinical Metagenomic Next-Generation Sequencing. Open Forum Infect Dis 2021; 8:ofab555.
  114. Teng XQ, Gong WC, Qi TT, et al. Clinical Analysis of Metagenomic Next-Generation Sequencing Confirmed Chlamydia psittaci Pneumonia: A Case Series and Literature Review. Infect Drug Resist 2021; 14:1481.
  115. Wang K, Liu X, Liu H, et al. Metagenomic diagnosis of severe psittacosis using multiple sequencing platforms. BMC Genomics 2021; 22:406.
  116. Duan Z, Gao Y, Liu B, et al. The Application Value of Metagenomic and Whole-Genome Capture Next-Generation Sequencing in the Diagnosis and Epidemiological Analysis of Psittacosis. Front Cell Infect Microbiol 2022; 12:872899.
  117. BioFire. The BioFire® FilmArray® Respiratory (RP & RP2) Panels. https://www.biofiredx.com/products/the-filmarray-panels/filmarrayrp/?gclid=CjwKCAjw5p_8BRBUEiwAPpJO63n6HAj1nJ39I2m6AY7o9uXQZJiVzd2GVzNlKAkgZLxihY4k9uF2IhoCLoQQAvD_BwE (Accessed on November 02, 2020).
  118. Viracor. Respiratory Pathogen Panel TEM-PCR™. https://www.viracor-eurofins.com/test-menu/220098p-respiratory-pathogen-panel-tem-pcr/ (Accessed on November 02, 2020).
  119. Hammers-Berggren S, Granath F, Julander I, Kalin M. Erythromycin for treatment of ornithosis. Scand J Infect Dis 1991; 23:159.
  120. Khatib R, Thirumoorthi MC, Kelly B, Grady KJ. Severe psittacosis during pregnancy and suppression of antibody response with early therapy. Scand J Infect Dis 1995; 27:519.
  121. Leroy O, Beuscart C, Chidiac C, et al. [Treatment of pneumonia caused by Legionella, Mycoplasma, Chlamydiae and Rickettsia using ofloxacin]. Pathol Biol (Paris) 1989; 37:1137.
  122. Ran O, Liang M, Yu J, et al. Recombinant protein CPSIT_0846 induces protective immunity against Chlamydia psittaci infection in BALB/c mice. Pathog Dis 2017; 75.
  123. Li Y, Zheng K, Tan Y, et al. A recombinant multi-epitope peptide vaccine based on MOMP and CPSIT_p6 protein protects against Chlamydia psittaci lung infection. Appl Microbiol Biotechnol 2019; 103:941.
  124. Balsamo G, Maxted AM, Midla JW, et al. Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017. J Avian Med Surg 2017; 31:262.
  125. Lederer P, Müller R. [Ornithosis--studies in correlation with an outbreak]. Gesundheitswesen 1999; 61:614.
  126. Williams CJ, Sillis M, Fearne V, et al. Risk exposures for human ornithosis in a poultry processing plant modified by use of personal protective equipment: an analytical outbreak study. Epidemiol Infect 2013; 141:1965.
  127. Van Droogenbroeck C, Van Risseghem M, Braeckman L, Vanrompay D. Evaluation of bioaerosol sampling techniques for the detection of Chlamydophila psittaci in contaminated air. Vet Microbiol 2009; 135:31.
Topic 7015 Version 32.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟